News
Check out the posts below to learn the latest updates on our progress
- March 31 2019F1 Oncology to Present Data That Expands on Proof of Novel Point of Care Approach for CAR-T Therapies in Solid Tumor Malignancies
Business Wire - March 29 2019Taking the Next Step: What We’ve Learned About CAR-T So Far, and What It Means Going Forward
- January 6 2019Cancer Doesn’t See Borders – And Neither Should Biotech
- November 13 2018F1 Oncology’s International Affiliate, EXUMA Biotechnology, Announces Acquisition of Strategic CAR-T Assets
- November 13 2018F1 ONCOLOGY’S INTERNATIONAL AFFILIATE, EXUMA BIOTECHNOLOGY, ANNOUNCES ACQUISITION OF STRATEGIC CAR-T ASSETSPRNewswire
- September 14 2018Keynote Announcement: BioFlorida Conference 2018
- January 7 2018F1 Oncology’s International Affiliates and Sinobioway Sunterra Biotechnology Announce New Development, Manufacturing, and Supply Agreements to Support cGMP Lentivirus SupplyPRNewswire
- January 7 2018F1 Oncology Announces Development Milestone and $10M Equity InvestmentPRNewswire
- January 6 2017BioAtla and F1 Oncology Announce Global Collaboration to Develop Adoptive Cellular Therapies for Solid Tumors